ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,506.98
-0.88%
US Tech 100
18,953.60
-1.41%
Dow Jones
40,208.10
-0.37%
Brent Oil
80.85
0.09%
Bitcoin
66,740.82
1.25%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cingulate Inc (CING)

  7. Cingulate Inc (CING) News

CING

Cingulate (CING)

Cingulate Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CING
DateTimeSourceHeadlineSymbolCompany
07/22/20245:04PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CINGCingulate Inc
07/16/20247:14PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CINGCingulate Inc
07/15/20245:06PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CINGCingulate Inc
07/15/20245:01PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CINGCingulate Inc
07/12/20245:11PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CINGCingulate Inc
07/12/20244:30PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CINGCingulate Inc
06/28/20249:15AMGlobeNewswire Inc.Cingulate Announces Exercise of Warrants for $1.86 Million Gross ProceedsNASDAQ:CINGCingulate Inc
06/25/20244:30PMGlobeNewswire Inc.Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access EventNASDAQ:CINGCingulate Inc
06/25/20249:20AMGlobeNewswire Inc.Cingulate Achieves Key Manufacturing Milestone in the Development of its ADHD Drug CTx-1301 in Preparation for FDA Marketing ClearanceNASDAQ:CINGCingulate Inc
05/21/20249:00AMGlobeNewswire Inc.FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHDNASDAQ:CINGCingulate Inc
05/08/20247:00AMGlobeNewswire Inc.Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business UpdateNASDAQ:CINGCingulate Inc
04/30/20245:45AMGlobeNewswire Inc.Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live AccessNASDAQ:CINGCingulate Inc
04/16/20245:00PMGlobeNewswire Inc.Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024NASDAQ:CINGCingulate Inc
04/01/20248:00AMGlobeNewswire Inc.Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business UpdateNASDAQ:CINGCingulate Inc
03/19/20244:45PMGlobeNewswire Inc.Cingulate to Participate in Benzinga All Live Access EventNASDAQ:CINGCingulate Inc
03/06/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGCingulate Inc
03/06/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGCingulate Inc
03/06/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGCingulate Inc
03/06/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGCingulate Inc
03/06/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGCingulate Inc
03/06/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGCingulate Inc
03/06/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGCingulate Inc
03/06/20246:45AMGlobeNewswire Inc.Cingulate to Attend DCAT Week 2024 in New York CityNASDAQ:CINGCingulate Inc
02/26/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGCingulate Inc
02/14/20245:00PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CINGCingulate Inc
02/13/20246:50AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGCingulate Inc
02/13/20246:45AMGlobeNewswire Inc.Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of DirectorsNASDAQ:CINGCingulate Inc
02/09/20249:00AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CINGCingulate Inc
02/09/20246:28AMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CINGCingulate Inc
02/06/20244:15PMGlobeNewswire Inc.Cingulate Announces Closing of $7.5 Million Public OfferingNASDAQ:CINGCingulate Inc
 Showing the most relevant articles for your search:NASDAQ:CING

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
KEGS
1812 Brewing (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
ENZC
Enzolytics (PK)
USOTC
ITUP
Interups (CE)
NASDAQ
TSLA
Tesla
USOTC
NWPN
Now (PK)
NASDAQ
NB
NioCorp Developments
NASDAQ
PLUG
Plug Power
USOTC
AABB
Asia Broadband (PK)
NYSE
AMC
AMC Entertainment
USOTC
RDGL
Vivos (QB)
USOTC
SMCE
SMC Entertainment (PK)
USOTC
IDVV
International Endeavors (PK)
NASDAQ
COOP
Mr Cooper
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved